Tagrisso (Osimertinib)

Tagrisso is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Tagrissois used to treat non-small cell lung cancer that is positive for an abnormal EGFR gene. You doctor will test you for this gene. Tagrisso is sometimes given when the cancer has spread to other parts of the body (metastatic) or to help prevent your lung cancer from coming back after your tumor(s) has been removed by surgery.

Ingredients

OSIMERTINIB MESYLATE

Cautions

Tagrisso may cause lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your doctor right away if you have any new or worsening lung symptoms, including trouble breathing, shortness of breath, cough, or fever.

Side Effects

Get emergency medical help if you have signs of an allergic reaction to Tagrisso (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling). Call your doctor at once if you have: skin redness or purple spots that don't turn pale when pressed, and that still look red or bruised after 24 hours (may appear on your arms, legs, buttocks, or midsection); redness, rash, or blisters on the palms of your hands or the soles of your feet; new or worsening cough or trouble breathing; fast or pounding heartbeats; swelling in your lower legs, weight gain, feeling short of breath; a light-headed feeling, like you might pass out; low blood cell counts - fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet; or eye problems - vision changes, watery eyes, increased sensitivity to light, eye pain or redness.